Literature DB >> 18677071

Breast and cervical cancer screening among low-income women in Nebraska: findings from the Every Woman Matters program, 1993-2004.

Shingairai A Feresu1, Wanqing Zhang, Susan E Puumala, Fred Ullrich, James R Anderson.   

Abstract

OBJECTIVE: To examine the likelihood of enrollees in the Nebraska Every Woman Matters program being screened for breast and cervical cancer.
METHODS: We explored the relationship between sociodemographic characteristics and receiving cancer screening services.
RESULTS: Older and Native American women were more likely than younger and White women to have mammograms ordered [adjusted odds ratio (OR)=1.41, 95% confidence interval (CI) 1.08, 1.85]. African American [OR=0.54, 95% CI 0.46, 0.64] and Native American women [OR=0.47, 95% CI 0.39, 0.55] were less likely than White women to have clinical breast exams performed. Native American [OR=0.19, 95% CI 0.16, 0.23] and African American women [OR=0.56, 95% CI 0.46, 0.68] were less likely than White women to have a Pap test performed.
CONCLUSION: Receiving cancer screening services was related to race; thus, understanding barriers for screening for minority women is warranted.

Entities:  

Mesh:

Year:  2008        PMID: 18677071     DOI: 10.1353/hpu.0.0065

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  3 in total

1.  Identifying barriers to Papanicolaou smear screening in Korean women: Korean National Health and Nutrition Examination Survey 2005.

Authors:  Su Jeong Park; Woong-Sub Park
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

2.  African-American caregivers' breast health behavior.

Authors:  Megumi Inoue; Joseph G Pickard; Patricia Welch-Saleeby; Sharon Johnson
Journal:  Health Educ Res       Date:  2009-03-23

3.  Socially-assigned race, healthcare discrimination and preventive healthcare services.

Authors:  Tracy Macintosh; Mayur M Desai; Tene T Lewis; Beth A Jones; Marcella Nunez-Smith
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.